Abstract
Objective
To study the effect of using recombinant human growth hormone (rhGH) in growth retarded children with chronic kidney disease (CKD)
Methods
This was a non-randomized controlled study over 2 years including children in CKD stages 4–5 suffering from growth retardation. Children were divided into rhGH-treated or non-rhGH treated groups.
Results
A total of 70 children (35 in each group) were enrolled. While the mean (SD) height of 35 children with CKD had increased from 109.5 (26) cm to 116 (26) cm (mean growth velocity 6.5 cm/year; P=0.09) prior to rhGH therapy, the same was found to increase from 116 (26) cm at the start of therapy to 125 (25) cm after one year of therapy (P=0.02).
Conclusions
Therapy with rhGH was helpful in catch-up growth in Tunisian children with CKD.
Similar content being viewed by others
References
Stevens PE, Levin A. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: improving global outcomes 2012 clinical practice guidelines. Ann Intern Med. 2013;158:825–30.
Ingulli EG, Mak RH. Growth in children with chronic kidney disease: Role of nutrition, growth hormone, dialysis and steroids. Curr Opin Pediatr. 2014;26:187–92.
Mian A, Schwartz GJ. Measurement and estimation of glomerular filtration rate in children. Adv Chronic Kidney Dis. 2017;24:348–56.
KDOQI Work Group. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis. 2009;53:S11–104.
Locatelli F, Bárány P, Covic A, et al. Kidney Disease: Improving Global Outcomes guidelines on Anaemia Management in Chronic Kidney Disease: A European Renal Best Practice Position statement. Nephrol Dial Transplant. 2013;28:1346–59.
Uhlig K, Berns JS, Kestenbaum B, et al. KADOQI US commentary on the KDIGO clinical practice guidelines for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder. Am J Kidney Disease. 2010;55:773–99.
Ismaili K, Schurmans T, Wissing KM, et al. Early prognostic factors of infants with chronic renal failure caused by renal dysplasia. Pediatr Nephrol. 2001;16:260–4.
Zivienjak M, Franke D, Filler G, et al. Growth impairment shows an age-dependent pattern in boys with chronic kidney disease. Pediatr Nephrol. 2007;22:420–9.
Karlberg J, Schaefer F, Hennicke M, Wingen AM, Rigden S, Mehls O. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. Early age- dependent growth impairment in chronic renal failure. Pediatr Nephrol. 1999;10:283
Marlais M, Stojanovic J, Jones H, et al. Catch-up growth in children with chronic kidney disease started on enteral feeding after 2 years of age. Pediatr Nephrol. 2020;35:113–18.
Van Dyck M, Bilem N, Proesmans W. Conservative treatment for chronic renal failure from birth: A 3-year follow-up study. Pediatr Nephrol. 1999;13:865–86919.
Larson-Nath C, Goday P. Malnutrition in children with chronic disease. Nutr Clin Pract. 2019;34:349–58.
Franz S. Section XI — Chronic kidney disease-endocrine and growth disorders in chronic renal failure. In: Avner, Ellis D, Harmon, William E, Niaudet P, eds. Pediatric Nephrology 5th Ed. Lippincott Williams & Wilkins; 2004. p.1313–45.
Drube J, Wan M, Bonthuis M, et al. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol. 2019;15: 577–89.
Rhie YJ, Yoo JH, Choi JH, et al. Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG growth study. PLoS One. 2019;14:e0216927.
Funding
Funding: None
Author information
Authors and Affiliations
Contributions
Contributors: AB: concept and designed the study, analyzed data and drafted the manuscript; RL: collected the data, helped in data analysis; MJ: helped in collecting data, and manuscript drafting; ON: supervised cognitive and behavioral assessments; TG: supervised cognitive and behavioral assessments
Corresponding author
Ethics declarations
Ethics clearance: Ethic committee of Charles Nicolle Hospital; No. Tun23032016, dated March 23, 2016.
Competing interest: None stated.
Rights and permissions
About this article
Cite this article
Boussetta, A., Laamouri, R., Jellouli, M. et al. Efficacy of Growth Hormone Treatment in Children With Chronic Kidney Disease: Tunisian Experience. Indian Pediatr 58, 1140–1142 (2021). https://doi.org/10.1007/s13312-021-2395-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-021-2395-z